XIANG, NAN – Trademark Portfolio

Entity Type: 01

XIANG, NAN holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 10 filings in this category. Currently, 10 trademarks are registered. Notable registered marks include 5AYN, DAYTHI, DIMAIR, ENVONI, and GERBUM. The owner is based in SHENZHEN,GUANGDONG.

5 / F, BUILDING A, BAIYING MEDICAL

INSTRUMENT, PARK, NO. 1019, NANHAI AVENUE, NANSHAN DISTRICT,

SHENZHEN,GUANGDONG 518000 , CN

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

5AYN
5AYN
Registered 2021
DIMAIR
DIMAIR
Registered 2020
ENWEYCI
ENWEYCI
Registered 2020
PUAUKI
PUAUKI
Registered 2020
QUXYWO
QUXYWO
Registered 2020
DAYTHI
DAYTHI
Registered 2020
ROPIRABA
ROPIRABA
Registered 2020
ENVONI
ENVONI
Registered 2020
GERBUM
GERBUM
Registered 2020
NOSAKKI
NOSAKKI
Registered 2019

Trademark Classifications

XIANG, NAN's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (10 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does XIANG, NAN have?

XIANG, NAN has 10 U.S. trademarks filed with the USPTO. Of these, 10 registered.

What trademark classes does XIANG, NAN file in?

XIANG, NAN files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are XIANG, NAN's most well-known trademarks?

XIANG, NAN's registered trademark portfolio includes well-known marks such as 5AYN, DAYTHI, DIMAIR, ENVONI, and GERBUM. These are among 10 currently registered trademarks in the portfolio.

What is XIANG, NAN's trademark registration success rate?

XIANG, NAN has a 100% trademark registration rate, with 10 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.